PHA 543613

PHA 543613
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T23145-1mg 1 mg

7 - 10 business days*

44.00€
TGM-T23145-1mL 1 ml

7 - 10 business days*

101.00€
TGM-T23145-5mg 5 mg

7 - 10 business days*

103.00€
TGM-T23145-10mg 10 mg

7 - 10 business days*

168.00€
TGM-T23145-25mg 25 mg

7 - 10 business days*

375.00€
TGM-T23145-50mg 50 mg

7 - 10 business days*

641.00€
TGM-T23145-100mg 100 mg

7 - 10 business days*

942.00€
TGM-T23145-500mg 500 mg

7 - 10 business days*

2,048.00€
 
Description: PHA 543613 is a specific agonist of alpha7 nAChR (Ki = 8.8 nM) and can be used in... more
Product information "PHA 543613"
Description: PHA 543613 is a specific agonist of alpha7 nAChR (Ki = 8.8 nM) and can be used in studies about the cognitive deficits of Alzheimer's disease and schizophrenia. Target: Others, AChR. Smiles: O=C(N[C@H]1CN2CCC1CC2)c1cc2ccoc2cn1. References: Donn G Wishka, et al. Discovery of N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide, an agonist of the alpha7 nicotinic acetylcholine receptor, for the potential treatment of cognitive deficits in schizophrenia: synthesis and structure--activity relationship. J Med Chem. 2006 Jul 13,49(14):4425-36. [Content Brief]
Supplier: TargetMol
Supplier-Nr: T23145

Properties

MW: 271.31 D
Formula: C15H17N3O2

Database Information

CAS : 478149-53-0| Matching products

Handling & Safety

Storage: -20°C
Shipping: +4°C (International: +4°C)
Signal Word: Warning
GHS Hazard Pictograms:
H Phrases: H319
P Phrases: P264, P280, P305+351+338, P337+313
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "PHA 543613"
Write a review
or to review a product.
Viewed